SlideShare a Scribd company logo
1 of 24
Download to read offline
CDC2010
Sexually Transmitted Diseases
Updated Summary of
	 CDC Treatment Guidelines
Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines)
These summary guidelines reflect the August 2012 update to the 2010 CDC Guidelines for
Treatment of Sexually Transmitted Diseases. CDC issues new recommendations for treating
uncomplicated gonorrhea in this update.
This summary is intended as a source of clinical guidance. When more than one therapeutic
regimen is recommended the sequence is in alphabetical order unless the choices for therapy are
prioritized based on efficacy, cost, or convenience. The recommended regimens should be used
primarily; alternative regimens can be considered in instances of substantial drug allergy or other
contraindications. An important component of STD treatment is partner management. Providers
can arrange for the evaluation and treatment of sex partners either directly or with assistance
from state and local health departments.
Complete guidelines can be viewed online at www.cdc.gov/std/treatment/2010.
This booklet has been reviewed by the CDC 8/2012.
Indicates revision from the 2006 CDC Guidelines for the Treatment of Sexually Transmitted Diseases.
Indicates update from the 2010 CDC Guidelines for the Treatment of Sexually Transmitted Diseases; see MMWR
Morb Mortal Wkly Rep. 2012 Aug 10; 61(31):590-594 for details.
Bacterial Vaginosis
Cervicitis
Chlamydial Infections
Epididymitis
Genital Herpes Simplex
Genital Warts (Human Papillomavirus)
Gonococcal Infections
Lymphogranuloma venereum
Non-Gonococcal Urethritis (NGU)
Pediculosis Pubis
Pelvic Inflammatory Disease
Scabies
Syphilis
Trichomoniasis
Bacterial Vaginosis
Recommended Rx Dose/Route Alternatives
Nonpregnant women metronidazole oral1
metronidazole gel 0.75%1
clindamycin cream 2%1,2
OR
OR
500 mg orally 2x/day for 7 days
One 5 g applicator intravaginally 1x/
day for 5 days
One 5 g applicator intravaginally at
bedtime for 7 days
tinidazole 2 g orally 1x/day for
2 days
tinidazole 1 g orally 1x/day for
5 days
clindamycin 300 mg orally 2x/day
for 7 days
clindamycin ovules 100 mg intravag-
inally at bedtime for 3 days
OR
OR
OR
Pregnancy3,4
metronidazole oral1
clindamycin oral
OR 500 mg orally 2x/day for 7 days or
250 mg orally 3x/day for 7 days
300 mg orally 2x/day for 7 days;
See complete guidelines for dosing
Bacterial
Vaginosis
Recommended Rx Dose/Route Alternatives
azithromycin
doxycycline6
OR 1 g orally in a single dose
100 mg orally 2x/day for 7 days
Cervicitis5
Cervicitis
Recommended Rx Dose/Route Alternatives
Adults, adolescents and chil-
dren aged >8 years
azithromycin
doxycycline6
OR 1 g orally in a single dose
100 mg orally 2x/day for 7 days
erythromycin base7
500 mg orally
4x/day for 7 days
erythromycin ethylsuccinate8
800 mg
orally 4x/day for 7 days
levofloxacin9
500 mg 1x/day orally
for 7 days
ofloxacin9
300 mg orally 2x/day for
7 days
OR
OR
OR
Pregnancy3
azithromycin10
amoxicillin
OR 1 g orally in a single dose
500 mg orally 3x/day for 7 days
erythromycin base7,11
500 mg orally
4x/day for 7 days
erythromycin base 250 mg orally 4x/
day for 14 days
erythromycin ethylsuccinate 800 mg
orally 4x/day for 7 days
erythromycin ethylsuccinate 400 mg
orally 4x/day for 14 days
OR
OR
OR
Children (<45 kg): urogenital,
rectal
erythromycin base12
or
ethylsuccinate
50 mg/kg/day orally (4 divided doses) daily for
14 days
Neonates: opthalmia neonato-
rum, pneumonia
erythromycin base12
or
ethylsuccinate
50 mg/kg/day orally (4 divided doses) daily for
14 days
Chlamydial Infections
Chlamydial
Infections
Recommended Rx Dose/Route Alternatives
For acute epididymitis
most likely due to
enteric organisms
or with negative GC
culture or NAAT:
ceftriaxone
doxycycline
levofloxacin
ofloxacin
PLUS
OR
250 mg IM in a single dose
100 mg orally 2x/day for 10 days
500 mg orally 1x/day for 10 days
300 mg orally 2x/day for 10 days
Epididymitis13,14
Epididymitis
Genital Herpes
Simplex
Recommended Rx Dose/Route Alternatives
First clinical episode of genital
herpes
acyclovir
acyclovir
famciclovir15
valacyclovir15
OR
OR
OR
400 mg orally 3x/day for 7-10 days16
200 mg orally 5x/day for 7-10 days16
250 mg orally 3x/day for 7-10 days16
1 g orally 2x/day for 7-10 days16
Episodic therapy for recurrent
genital herpes
acyclovir
acyclovir
acyclovir
famciclovir15
famciclovir15
famciclovir15
valacyclovir15
valacyclovir15
OR
OR
OR
OR
OR
OR
OR
400 mg orally 3x/day for 5 days
800 mg orally 2x/day for 5 days
800 mg orally 3x/day for 2 days
125 mg orally 2x/day for 5 days
1000 mg orally 2x/day for 1 day16
500 mg orally once, followed by 250 mg 2x/day
for 2 days
500 mg orally 2x/day for 3 days
1 g orally 1x/day for 5 days
Suppressive therapy17
for
recurrent genital herpes
acyclovir
famciclovir15
valacyclovir15
valacyclovir15
OR
OR
OR
400 mg orally 2x/day
250 mg orally 2x/day
500 mg orally once a day
1 g orally once a day
Recommended regimens for
episodic infection in persons
with HIV infection
acyclovir
famciclovir15
valacyclovir15
OR
OR
400 mg orally 3x/day for 5-10 days
500 mg orally 2x/day for 5-10 days
1 g orally 2x/day for 5-10 days
Recommended regimens for daily
suppressive therapy in persons
with HIV infection
acyclovir
famciclovir15
valacyclovir15
OR
OR
400-800 mg orally 2-3x/day
500 mg orally 2x/day
500 mg orally 2x/day
Genital Herpes Simplex
Genital Warts
(Human
Papillomavirus)
Recommended Rx Dose/Route Alternatives
External genital and perianal
warts
Patient Applied
podofilox 0.5%15
solution or gel
imiquimod 5%15
cream
sinecatechins 15% ointment2,15
Provider Administered
Cryotherapy
podophyllin resin 10%-25%15
trichloroacetic acid or
bichloroacetic acid 80%-90%
surgical removal
OR
OR
OR
OR
OR
Apply to visible warts 2x/day for 3
days, rest 4 days, 4 cycles max.
Apply once h.s., wash off after 6-10
hours 3x/week QOD, 16 weeks max.
Apply 3x/day, 16 weeks max; See
complete CDC guidelines.
Apply small amount, dry, wash off in
1-4 hours. Repeat weekly if necessary
Apply small amount, dry, apply weekly
if necessary
Intralesional interferon
Laser surgery
OR
Genital Warts (Human Papillomavirus)18
Gonococcal
Infections
Recommended Rx Dose/Route Alternatives
Adults, adolescents, and
children >45 kg: urogenital,
rectal
ceftriaxone
PLUS
azithromycin10
doxycycline6
OR
OR
250 mg IM in a single dose
1 g orally in a single dose
100 mg orally 2x/day for 7 days
cefixime20
400 mg orally in a single dose
azithromycin10
1 g orally in a single dose
doxycycline6
100 mg 2x/day for 7 days
test-of-cure
If the patient has severe cephalosporin
allergy:
azithromycin 2 g orally in a single dose
test-of-cure
PLUS
OR
PLUS
PLUS
Pharyngeal21 ceftriaxone
PLUS
azithromycin10
doxycycline6
OR
250 mg IM in a single dose
1 g orally in a single dose
100 mg orally 2x/day for 7 days
Pregnancy3
See complete CDC guidelines.
Adults and adolescents:
conjunctivitis
ceftriaxone 1 g IM in a single dose; irrigate infected
eye with saline solution once
Children (≤45 kg): urogenital,
rectal, pharyngeal
ceftriaxone22
125 mg IM in a single dose
Gonococcal Infections19
Lymphogranuloma
venereum
Recommended Rx Dose/Route Alternatives
doxycycline6
100 mg orally 2x/day for 21 days erythromycin base 500 mg
orally 4x/day for 21 days
Lymphogranuloma venereum
Non-Gonococcal
Urethritis (NGU)
Recommended Rx Dose/Route Alternatives
azithromycin10
doxycycline6
OR 1 g orally in a single dose
100 mg orally 2x/day for 7 days
erythromycin base7
500 mg orally
4x/day for 7 days
erythromycin ethylsuccinate8
800
mg orally 4x/day for 7 days
levofloxacin 500 mg 1x/day for 7
days
ofloxacin 300 mg 2x/day for 7 days
OR
OR
OR
Recurrent NGU3,23,24
metronidazole25
tinidazole
OR
PLUS
2 g orally in a single dose
2 g orally in a single dose
1 g orally in a single doseazithromycin (if not used for initial episode)
Nongonococcal Urethritis (NGU)
Pediculosis
Pubis
Recommended Rx Dose/Route Alternatives
permethrin 1% cream rinse
pyrethrins with piperonyl
butoxide
OR Apply to affected area, wash off after 10 minutes
Apply to affected area, wash off after 10 minutes
malathion 0.5% lotion, applied
8-12 hrs then washed off
ivermectin 250 µg/kg orally,
repeated in 2 weeks
OR
Pediculosis Pubis
Pelvic
Inflammatory
Disease
Recommended Rx Dose/Route Alternatives
1. ceftriaxone
doxycycline	
With OR
metronidazole
2. cefoxitin
doxycycline	
With OR
metronidazole
3. Other parenteral third-
generation cephalosporin
(e.g. ceftizoxime or cefo-
taxime)
doxycycline	
With OR
metronidazole
PLUS
Without
PLUS
Without
PLUS
Without
250 mg IM in a single dose
100 mg orally 2x/day for 14 days
500 mg orally 2x/day for 14 days
2 g IM in a single dose and probenecid,
1 g, orally administered concurrently
in a single dose
100 mg orally 2x/day for 14 days
500 mg orally 2x/day for 14 days
100 mg orally 2x/day for 14 days
500 mg orally 2x/day for 14 days
Pelvic Inflammatory Disease13
Alternative oral regimens are listed in CDC’s 2010 STD Treatment Guidelines.
Scabies
Recommended Rx Dose/Route Alternatives
permethrin 5% cream
ivermectin
OR Apply to all areas of body from neck down, wash
off after 8-14 hours
200 µg/kg orally, repeated in 2 weeks
lindane 1%26,27
1 oz. of lotion or
30 g of cream, applied thinly
to all areas of the body from
the neck down, wash off after
8 hours
Scabies
Recommended Rx Dose/Route Alternatives
Primary, secondary, or early
latent 1 year
benzathine penicillin G 2.4 million units IM in a single dose doxycycline6,28
100 mg 2x/day for 14 days
tetracycline6,28
500 mg orally 4x/day for
14 days
OR
Latent 1 year, latent of
unknown duration
benzathine penicillin G 2.4 million units IM in 3 doses each at
1 week intervals (7.2 million units
total)
doxycycline6,28
100 mg 2x/day for 28 days
tetracycline6,28
500 mg orally 4x/day for
28 days
OR
Pregnancy3
See complete CDC guidelines.
Neurosyphilis aqueous crystalline penicillin G 3 to 4 million units IV every 4 hours
for 10-14 days (18-24 million units/
day)
procaine penicillin G 2.4 MU IM 1x daily
probenecid 500 mg orally 4x/day, both for
10-14 days.
PLUS
Congenital syphilis aqueous crystalline penicillin G
procaine penicillin G
OR 100,000-150,000 units/kg/day (50,000
units/kg/dose IV every 12 hours) dur-
ing the first 7 days of life and every 8
hours thereafter for a total of 10 days
50,000 units/kg/dose IM in a single dose
for 10 days
Children: Primary, secondary,
or early latent 1 year
benzathine penicillin G 50,000 units/kg IM in a single dose
(maximum 2.4 million units)
Children: Latent 1 year,
latent of unknown duration
benzathine penicillin G 50,000 units/kg IM for 3 doses at 1
week intervals (maximum total 7.2
million units)
Syphilis
Syphilis
Trichomoniasis
Recommended Rx Dose/Route Alternatives
metronidazole25
tinidazole29
OR 2 g orally in a single dose
2 g orally in a single dose
metronidazole25
500 mg 2x/day for 7 days
Trichomoniasis
1.	 The recommended regimens are equally efficacious.
2.	 These creams are oil-based and may weaken latex condoms and diaphragms. Refer to product labeling for further information.
3.	 Please refer to the complete 2010 CDC Guidelines for recommended regimens.
4.	 Existing data do not support the use of topical agents in pregnancy.
5.	 Consider concurrent treatment for gonococcal infection if prevalence of gonorrhea is 5% (younger age).
6.	 Should not be administered during pregnancy, lactation, or to children 8 years of age.
7.	 If patient cannot tolerate high-dose erythromycin base schedules, change to 250 mg 4x/day for 14 days.
8.	 If patient cannot tolerate high-dose erythromycin ethylsuccinate schedules, change to 400 mg orally 4 times a day for 14 days.
9.	 Contraindicated for pregnant or lactating women.
10.	 Clinical experience and published studies suggest that azithromycin is safe and effective.
11.	 Erythromycin estolate is contraindicated during pregnancy.
12.	 Effectiveness of erythromycin treatment is approximately 80%; a second course of therapy may be required.
13.	 Patients who do not respond to oral therapy (within 72 hours) should be re-evaluated.
14	 For patients with suspected sexually transmitted epididymitis, close follow-up is essential.
15.	 No definitive information available on prenatal exposure.
16.	 Treatment may be extended if healing is incomplete after 10 days of therapy.
	 Indicates revision from the 2006 CDC Guidelines for the Treatment of Sexually Transmitted Diseases.		
	 Indicates update from the 2010 CDC Guidelines for the Treatment of Sexually Transmitted Diseases; see MMWR Morb Mortal Wkly Rep. 2012 Aug 10; 61(31):590-594
for details.
Notes
Notes
17.	 Consider discontinuation of treatment after one year to assess frequency of recurrence.
18.	 Vaginal, cervical, urethral meatal, and anal warts may require referral to an appropriate specialist.
19.	 CDC recommends that treatment for uncomplicated gonococcal infections of the cervix, urethra, and/or rectum
should include dual therapy, i.e. both a cephalosporin (e.g. ceftriaxone) plus azithromycin (preferred) or doxycycline.
20.	 CDC recommends that cefixime in combination with azithromycin or doxycycline be used as an alternative when ceftriaxone is not available.
21.	 Only ceftriaxone is recommended for the treatment of pharyngeal infection. Providers should inquire about oral sexual exposure
22.	 Use with caution in hyperbilirubinemic infants, especially those born prematurely.
23.	 MSM are unlikely to benefit from the addition of nitroimidazoles.
24.	 Moxifloxacin 400mg orally 1x/day for 7 days effective against Mycoplasma genitalium
25.	 Pregnant patients can be treated with 2 g single dose.
26.	 Contraindicated for pregnant or lactating women, or children 2 years of age.
27.	 Do not use after a bath; should not be used by persons who have extensive dermatitis.
28.	 Pregnant patients allergic to penicillin should be treated with penicillin after desensitization.
29.	 Randomized controlled trials comparing single 2 g doses of metronidazole and tinidazole suggest that tinidazole is equivalent to,
or superior to, metronidazole in achieving parasitologic cure and resolution of symptoms.
	 Indicates revision from the 2006 CDC Guidelines for the Treatment of Sexually Transmitted Diseases.
	 Indicates update from the 2010 CDC Guidelines for the Treatment of Sexually Transmitted Diseases; see MMWR Morb Mortal Wkly Rep. 2012 Aug 10; 61(31):590-594
for details.
		
Notes (continued)
Notes
(continued)
Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines)
Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines)
Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines)
CS232861

More Related Content

Viewers also liked

Développement de méthodes rapides pour l'authentification des produits biolog...
Développement de méthodes rapides pour l'authentification des produits biolog...Développement de méthodes rapides pour l'authentification des produits biolog...
Développement de méthodes rapides pour l'authentification des produits biolog...Pôle Qualiméditerranée
 
Free Everything DiSC 363 for leaders report | Strengthscape
Free Everything DiSC 363 for leaders report | StrengthscapeFree Everything DiSC 363 for leaders report | Strengthscape
Free Everything DiSC 363 for leaders report | StrengthscapeStrengthscape
 
Интернет для специальности психолога - важнейшие информационные сайты
Интернет для специальности психолога - важнейшие информационные сайтыИнтернет для специальности психолога - важнейшие информационные сайты
Интернет для специальности психолога - важнейшие информационные сайтыFyisher
 
Роман Кокин «Организация тестирования в больших командах»
Роман Кокин «Организация тестирования в больших командах»Роман Кокин «Организация тестирования в больших командах»
Роман Кокин «Организация тестирования в больших командах»DataArt
 
Trinh dien ho so bai day
Trinh dien ho so bai dayTrinh dien ho so bai day
Trinh dien ho so bai dayheocon020192
 
Πάτρα και οι Ναοί της
Πάτρα και οι Ναοί τηςΠάτρα και οι Ναοί της
Πάτρα και οι Ναοί τηςgympeirp
 
Security & penetration testing
Security & penetration testingSecurity & penetration testing
Security & penetration testingGTestClub
 
12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...
12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...
12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...INCUBUS CONSULTING
 
(Pdf) yury chemerkin _icitst_2012
(Pdf) yury chemerkin _icitst_2012(Pdf) yury chemerkin _icitst_2012
(Pdf) yury chemerkin _icitst_2012STO STRATEGY
 
Кабінет Укр.мови
Кабінет Укр.мовиКабінет Укр.мови
Кабінет Укр.мовиOlga Poslovska
 
Analysis of magazine covers
Analysis of magazine coversAnalysis of magazine covers
Analysis of magazine coversSineadPaige
 

Viewers also liked (14)

Développement de méthodes rapides pour l'authentification des produits biolog...
Développement de méthodes rapides pour l'authentification des produits biolog...Développement de méthodes rapides pour l'authentification des produits biolog...
Développement de méthodes rapides pour l'authentification des produits biolog...
 
Free Everything DiSC 363 for leaders report | Strengthscape
Free Everything DiSC 363 for leaders report | StrengthscapeFree Everything DiSC 363 for leaders report | Strengthscape
Free Everything DiSC 363 for leaders report | Strengthscape
 
Интернет для специальности психолога - важнейшие информационные сайты
Интернет для специальности психолога - важнейшие информационные сайтыИнтернет для специальности психолога - важнейшие информационные сайты
Интернет для специальности психолога - важнейшие информационные сайты
 
Роман Кокин «Организация тестирования в больших командах»
Роман Кокин «Организация тестирования в больших командах»Роман Кокин «Организация тестирования в больших командах»
Роман Кокин «Организация тестирования в больших командах»
 
K circle-qotm-02082104
K circle-qotm-02082104K circle-qotm-02082104
K circle-qotm-02082104
 
Trinh dien ho so bai day
Trinh dien ho so bai dayTrinh dien ho so bai day
Trinh dien ho so bai day
 
Joomla! na MS Windows
Joomla! na MS WindowsJoomla! na MS Windows
Joomla! na MS Windows
 
Πάτρα και οι Ναοί της
Πάτρα και οι Ναοί τηςΠάτρα και οι Ναοί της
Πάτρα και οι Ναοί της
 
Security & penetration testing
Security & penetration testingSecurity & penetration testing
Security & penetration testing
 
12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...
12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...
12% Assured Return on Property in Noida Expressway “Cosmic Corporate Park-2”@...
 
(Pdf) yury chemerkin _icitst_2012
(Pdf) yury chemerkin _icitst_2012(Pdf) yury chemerkin _icitst_2012
(Pdf) yury chemerkin _icitst_2012
 
Кабінет Укр.мови
Кабінет Укр.мовиКабінет Укр.мови
Кабінет Укр.мови
 
Analysis of magazine covers
Analysis of magazine coversAnalysis of magazine covers
Analysis of magazine covers
 
Map presentation
Map presentationMap presentation
Map presentation
 

Similar to Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines)

Gynecology genital disease and treatment Dr. Ahmadi.pdf
Gynecology genital disease and treatment Dr. Ahmadi.pdfGynecology genital disease and treatment Dr. Ahmadi.pdf
Gynecology genital disease and treatment Dr. Ahmadi.pdfTayebehHeidari1
 
sexually transmitted diseases
sexually transmitted diseasessexually transmitted diseases
sexually transmitted diseasesTevfik Yoldemir
 
Acyclovir
AcyclovirAcyclovir
AcyclovirAya Ali
 
Applications of antibiotics in dentistry /endodontic courses
Applications of antibiotics in dentistry /endodontic coursesApplications of antibiotics in dentistry /endodontic courses
Applications of antibiotics in dentistry /endodontic coursesIndian dental academy
 
1246_Antibiotic_Doses.pdf
1246_Antibiotic_Doses.pdf1246_Antibiotic_Doses.pdf
1246_Antibiotic_Doses.pdfsarfaraz ahmed
 
Malaria by affan ali(036)
Malaria by affan ali(036)Malaria by affan ali(036)
Malaria by affan ali(036)AFFAN ALI
 
Cefexta (Cefdinir) an extended spectrum antibiotic
Cefexta (Cefdinir) an extended spectrum antibioticCefexta (Cefdinir) an extended spectrum antibiotic
Cefexta (Cefdinir) an extended spectrum antibioticRezaur Rahman Siddiqui
 
Drug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistryDrug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistryDrKhyaati
 
Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...
Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...
Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...Dr. Aryan (Anish Dhakal)
 
What nelson forgot 2nd edn
What nelson forgot 2nd ednWhat nelson forgot 2nd edn
What nelson forgot 2nd ednGaurav Gupta
 
Rx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptxRx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptxMohammed Alhayani
 
Various drugs available in pediatric dentistry and calculation involved
Various drugs available in pediatric dentistry and calculation involvedVarious drugs available in pediatric dentistry and calculation involved
Various drugs available in pediatric dentistry and calculation involvedJeyashriTamilarasu
 
antibiotic and using in common infection
antibiotic and using in common infection antibiotic and using in common infection
antibiotic and using in common infection Y Alsfah
 
Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)abdullahsharaf55
 
Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)Ahmad Ali
 

Similar to Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines) (20)

2015 guia de cdc para tto de ets y vb
2015 guia de cdc para tto de ets y vb2015 guia de cdc para tto de ets y vb
2015 guia de cdc para tto de ets y vb
 
Gynecology genital disease and treatment Dr. Ahmadi.pdf
Gynecology genital disease and treatment Dr. Ahmadi.pdfGynecology genital disease and treatment Dr. Ahmadi.pdf
Gynecology genital disease and treatment Dr. Ahmadi.pdf
 
sexually transmitted diseases
sexually transmitted diseasessexually transmitted diseases
sexually transmitted diseases
 
sexually transmitted diseases
sexually transmitted diseasessexually transmitted diseases
sexually transmitted diseases
 
DOH National Antibiotic Guidelines 2016 (UTI)
DOH National Antibiotic Guidelines 2016 (UTI)DOH National Antibiotic Guidelines 2016 (UTI)
DOH National Antibiotic Guidelines 2016 (UTI)
 
Acyclovir
AcyclovirAcyclovir
Acyclovir
 
Applications of antibiotics in dentistry /endodontic courses
Applications of antibiotics in dentistry /endodontic coursesApplications of antibiotics in dentistry /endodontic courses
Applications of antibiotics in dentistry /endodontic courses
 
1246_Antibiotic_Doses.pdf
1246_Antibiotic_Doses.pdf1246_Antibiotic_Doses.pdf
1246_Antibiotic_Doses.pdf
 
Agmnt cfalosn
Agmnt cfalosnAgmnt cfalosn
Agmnt cfalosn
 
Malaria by affan ali(036)
Malaria by affan ali(036)Malaria by affan ali(036)
Malaria by affan ali(036)
 
Cefexta (Cefdinir) an extended spectrum antibiotic
Cefexta (Cefdinir) an extended spectrum antibioticCefexta (Cefdinir) an extended spectrum antibiotic
Cefexta (Cefdinir) an extended spectrum antibiotic
 
Drug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistryDrug dosage and antibiotics in pediatric dentistry
Drug dosage and antibiotics in pediatric dentistry
 
Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...
Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...
Essential Drugs Dosage and Formulations (Medical Booklet Series by Dr. Aryan ...
 
What nelson forgot 2nd edn
What nelson forgot 2nd ednWhat nelson forgot 2nd edn
What nelson forgot 2nd edn
 
Rx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptxRx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptx
 
Various drugs available in pediatric dentistry and calculation involved
Various drugs available in pediatric dentistry and calculation involvedVarious drugs available in pediatric dentistry and calculation involved
Various drugs available in pediatric dentistry and calculation involved
 
antibiotic and using in common infection
antibiotic and using in common infection antibiotic and using in common infection
antibiotic and using in common infection
 
Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)Antibioitcs guide choice for common infection (doc toon.page)
Antibioitcs guide choice for common infection (doc toon.page)
 
Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)Antibioitcs choices for common infections (2013 edition)
Antibioitcs choices for common infections (2013 edition)
 
Antibioitcs guide
Antibioitcs guideAntibioitcs guide
Antibioitcs guide
 

More from Global Medical Cures™

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaGlobal Medical Cures™
 
Global Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in AdultsGlobal Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in AdultsGlobal Medical Cures™
 
Global Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for BlacksGlobal Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for BlacksGlobal Medical Cures™
 
Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being Global Medical Cures™
 
Global Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs PricingGlobal Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs PricingGlobal Medical Cures™
 
Global Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana AbuseGlobal Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana AbuseGlobal Medical Cures™
 
Global Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful InteractionsGlobal Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful InteractionsGlobal Medical Cures™
 
Global Medical Cures™ | Medicines for Treating Depression
Global Medical Cures™  | Medicines for Treating DepressionGlobal Medical Cures™  | Medicines for Treating Depression
Global Medical Cures™ | Medicines for Treating DepressionGlobal Medical Cures™
 
Global Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & DepressionGlobal Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & DepressionGlobal Medical Cures™
 
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...Global Medical Cures™
 
Global Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic ResistanceGlobal Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic ResistanceGlobal Medical Cures™
 
Global Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for AmericansGlobal Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for AmericansGlobal Medical Cures™
 
Global Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for AmericansGlobal Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for AmericansGlobal Medical Cures™
 
Global Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your EyesGlobal Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your EyesGlobal Medical Cures™
 
Global Medical Cures™ | Help your Child gain control over Asthma
Global Medical Cures™  |  Help your Child gain control over AsthmaGlobal Medical Cures™  |  Help your Child gain control over Asthma
Global Medical Cures™ | Help your Child gain control over AsthmaGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone CancerGlobal Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone CancerGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast CancerGlobal Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast CancerGlobal Medical Cures™
 
Global Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck CancerGlobal Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck CancerGlobal Medical Cures™
 
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin LymphomaGlobal Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin LymphomaGlobal Medical Cures™
 
Global Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic CancerGlobal Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic CancerGlobal Medical Cures™
 

More from Global Medical Cures™ (20)

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
 
Global Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in AdultsGlobal Medical Cures™ - Screening for Skin Cancer in Adults
Global Medical Cures™ - Screening for Skin Cancer in Adults
 
Global Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for BlacksGlobal Medical Cures™ | USA Chartbook on HealthCare for Blacks
Global Medical Cures™ | USA Chartbook on HealthCare for Blacks
 
Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being Global Medical Cures™ | Older Americans- Key Indicators of Well Being
Global Medical Cures™ | Older Americans- Key Indicators of Well Being
 
Global Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs PricingGlobal Medical Cures™ | Staggering Increase in Generic Drugs Pricing
Global Medical Cures™ | Staggering Increase in Generic Drugs Pricing
 
Global Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana AbuseGlobal Medical Cures™ | Dangers & Consequences of Marijuana Abuse
Global Medical Cures™ | Dangers & Consequences of Marijuana Abuse
 
Global Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful InteractionsGlobal Medical Cures™ | Harmful Interactions
Global Medical Cures™ | Harmful Interactions
 
Global Medical Cures™ | Medicines for Treating Depression
Global Medical Cures™  | Medicines for Treating DepressionGlobal Medical Cures™  | Medicines for Treating Depression
Global Medical Cures™ | Medicines for Treating Depression
 
Global Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & DepressionGlobal Medical Cures™ | Women & Depression
Global Medical Cures™ | Women & Depression
 
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
Global Medical Cures™ | National Strategy for Combating Antibiotic Resistant ...
 
Global Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic ResistanceGlobal Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
Global Medical Cures™ | PCAST Report- Combating Antibiotic Resistance
 
Global Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for AmericansGlobal Medical Cures™ | Physical Activity Guidelines for Americans
Global Medical Cures™ | Physical Activity Guidelines for Americans
 
Global Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for AmericansGlobal Medical Cures™ | Dietary Guidelines for Americans
Global Medical Cures™ | Dietary Guidelines for Americans
 
Global Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your EyesGlobal Medical Cures™ | Aging and your Eyes
Global Medical Cures™ | Aging and your Eyes
 
Global Medical Cures™ | Help your Child gain control over Asthma
Global Medical Cures™  |  Help your Child gain control over AsthmaGlobal Medical Cures™  |  Help your Child gain control over Asthma
Global Medical Cures™ | Help your Child gain control over Asthma
 
Global Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone CancerGlobal Medical Cures™ | Drugs approved for Bone Cancer
Global Medical Cures™ | Drugs approved for Bone Cancer
 
Global Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast CancerGlobal Medical Cures™ | Drugs approved for Breast Cancer
Global Medical Cures™ | Drugs approved for Breast Cancer
 
Global Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck CancerGlobal Medical Cures™| Drugs approved for Head and Neck Cancer
Global Medical Cures™| Drugs approved for Head and Neck Cancer
 
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin LymphomaGlobal Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
Global Medical Cures™ | Drugs approved for Non Hodgkin Lymphoma
 
Global Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic CancerGlobal Medical Cures™ |Drugs approved for Pancreatic Cancer
Global Medical Cures™ |Drugs approved for Pancreatic Cancer
 

Recently uploaded

Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 

Recently uploaded (20)

Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 

Global Medical Cures™ | Sexually Transmitted Diseases (CDC Treatment Guidelines)

  • 1. CDC2010 Sexually Transmitted Diseases Updated Summary of CDC Treatment Guidelines
  • 3. These summary guidelines reflect the August 2012 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases. CDC issues new recommendations for treating uncomplicated gonorrhea in this update. This summary is intended as a source of clinical guidance. When more than one therapeutic regimen is recommended the sequence is in alphabetical order unless the choices for therapy are prioritized based on efficacy, cost, or convenience. The recommended regimens should be used primarily; alternative regimens can be considered in instances of substantial drug allergy or other contraindications. An important component of STD treatment is partner management. Providers can arrange for the evaluation and treatment of sex partners either directly or with assistance from state and local health departments. Complete guidelines can be viewed online at www.cdc.gov/std/treatment/2010. This booklet has been reviewed by the CDC 8/2012. Indicates revision from the 2006 CDC Guidelines for the Treatment of Sexually Transmitted Diseases. Indicates update from the 2010 CDC Guidelines for the Treatment of Sexually Transmitted Diseases; see MMWR Morb Mortal Wkly Rep. 2012 Aug 10; 61(31):590-594 for details.
  • 4. Bacterial Vaginosis Cervicitis Chlamydial Infections Epididymitis Genital Herpes Simplex Genital Warts (Human Papillomavirus) Gonococcal Infections Lymphogranuloma venereum Non-Gonococcal Urethritis (NGU) Pediculosis Pubis Pelvic Inflammatory Disease Scabies Syphilis Trichomoniasis
  • 5. Bacterial Vaginosis Recommended Rx Dose/Route Alternatives Nonpregnant women metronidazole oral1 metronidazole gel 0.75%1 clindamycin cream 2%1,2 OR OR 500 mg orally 2x/day for 7 days One 5 g applicator intravaginally 1x/ day for 5 days One 5 g applicator intravaginally at bedtime for 7 days tinidazole 2 g orally 1x/day for 2 days tinidazole 1 g orally 1x/day for 5 days clindamycin 300 mg orally 2x/day for 7 days clindamycin ovules 100 mg intravag- inally at bedtime for 3 days OR OR OR Pregnancy3,4 metronidazole oral1 clindamycin oral OR 500 mg orally 2x/day for 7 days or 250 mg orally 3x/day for 7 days 300 mg orally 2x/day for 7 days; See complete guidelines for dosing Bacterial Vaginosis
  • 6. Recommended Rx Dose/Route Alternatives azithromycin doxycycline6 OR 1 g orally in a single dose 100 mg orally 2x/day for 7 days Cervicitis5 Cervicitis
  • 7. Recommended Rx Dose/Route Alternatives Adults, adolescents and chil- dren aged >8 years azithromycin doxycycline6 OR 1 g orally in a single dose 100 mg orally 2x/day for 7 days erythromycin base7 500 mg orally 4x/day for 7 days erythromycin ethylsuccinate8 800 mg orally 4x/day for 7 days levofloxacin9 500 mg 1x/day orally for 7 days ofloxacin9 300 mg orally 2x/day for 7 days OR OR OR Pregnancy3 azithromycin10 amoxicillin OR 1 g orally in a single dose 500 mg orally 3x/day for 7 days erythromycin base7,11 500 mg orally 4x/day for 7 days erythromycin base 250 mg orally 4x/ day for 14 days erythromycin ethylsuccinate 800 mg orally 4x/day for 7 days erythromycin ethylsuccinate 400 mg orally 4x/day for 14 days OR OR OR Children (<45 kg): urogenital, rectal erythromycin base12 or ethylsuccinate 50 mg/kg/day orally (4 divided doses) daily for 14 days Neonates: opthalmia neonato- rum, pneumonia erythromycin base12 or ethylsuccinate 50 mg/kg/day orally (4 divided doses) daily for 14 days Chlamydial Infections Chlamydial Infections
  • 8. Recommended Rx Dose/Route Alternatives For acute epididymitis most likely due to enteric organisms or with negative GC culture or NAAT: ceftriaxone doxycycline levofloxacin ofloxacin PLUS OR 250 mg IM in a single dose 100 mg orally 2x/day for 10 days 500 mg orally 1x/day for 10 days 300 mg orally 2x/day for 10 days Epididymitis13,14 Epididymitis
  • 9. Genital Herpes Simplex Recommended Rx Dose/Route Alternatives First clinical episode of genital herpes acyclovir acyclovir famciclovir15 valacyclovir15 OR OR OR 400 mg orally 3x/day for 7-10 days16 200 mg orally 5x/day for 7-10 days16 250 mg orally 3x/day for 7-10 days16 1 g orally 2x/day for 7-10 days16 Episodic therapy for recurrent genital herpes acyclovir acyclovir acyclovir famciclovir15 famciclovir15 famciclovir15 valacyclovir15 valacyclovir15 OR OR OR OR OR OR OR 400 mg orally 3x/day for 5 days 800 mg orally 2x/day for 5 days 800 mg orally 3x/day for 2 days 125 mg orally 2x/day for 5 days 1000 mg orally 2x/day for 1 day16 500 mg orally once, followed by 250 mg 2x/day for 2 days 500 mg orally 2x/day for 3 days 1 g orally 1x/day for 5 days Suppressive therapy17 for recurrent genital herpes acyclovir famciclovir15 valacyclovir15 valacyclovir15 OR OR OR 400 mg orally 2x/day 250 mg orally 2x/day 500 mg orally once a day 1 g orally once a day Recommended regimens for episodic infection in persons with HIV infection acyclovir famciclovir15 valacyclovir15 OR OR 400 mg orally 3x/day for 5-10 days 500 mg orally 2x/day for 5-10 days 1 g orally 2x/day for 5-10 days Recommended regimens for daily suppressive therapy in persons with HIV infection acyclovir famciclovir15 valacyclovir15 OR OR 400-800 mg orally 2-3x/day 500 mg orally 2x/day 500 mg orally 2x/day Genital Herpes Simplex
  • 10. Genital Warts (Human Papillomavirus) Recommended Rx Dose/Route Alternatives External genital and perianal warts Patient Applied podofilox 0.5%15 solution or gel imiquimod 5%15 cream sinecatechins 15% ointment2,15 Provider Administered Cryotherapy podophyllin resin 10%-25%15 trichloroacetic acid or bichloroacetic acid 80%-90% surgical removal OR OR OR OR OR Apply to visible warts 2x/day for 3 days, rest 4 days, 4 cycles max. Apply once h.s., wash off after 6-10 hours 3x/week QOD, 16 weeks max. Apply 3x/day, 16 weeks max; See complete CDC guidelines. Apply small amount, dry, wash off in 1-4 hours. Repeat weekly if necessary Apply small amount, dry, apply weekly if necessary Intralesional interferon Laser surgery OR Genital Warts (Human Papillomavirus)18
  • 11. Gonococcal Infections Recommended Rx Dose/Route Alternatives Adults, adolescents, and children >45 kg: urogenital, rectal ceftriaxone PLUS azithromycin10 doxycycline6 OR OR 250 mg IM in a single dose 1 g orally in a single dose 100 mg orally 2x/day for 7 days cefixime20 400 mg orally in a single dose azithromycin10 1 g orally in a single dose doxycycline6 100 mg 2x/day for 7 days test-of-cure If the patient has severe cephalosporin allergy: azithromycin 2 g orally in a single dose test-of-cure PLUS OR PLUS PLUS Pharyngeal21 ceftriaxone PLUS azithromycin10 doxycycline6 OR 250 mg IM in a single dose 1 g orally in a single dose 100 mg orally 2x/day for 7 days Pregnancy3 See complete CDC guidelines. Adults and adolescents: conjunctivitis ceftriaxone 1 g IM in a single dose; irrigate infected eye with saline solution once Children (≤45 kg): urogenital, rectal, pharyngeal ceftriaxone22 125 mg IM in a single dose Gonococcal Infections19
  • 12. Lymphogranuloma venereum Recommended Rx Dose/Route Alternatives doxycycline6 100 mg orally 2x/day for 21 days erythromycin base 500 mg orally 4x/day for 21 days Lymphogranuloma venereum
  • 13. Non-Gonococcal Urethritis (NGU) Recommended Rx Dose/Route Alternatives azithromycin10 doxycycline6 OR 1 g orally in a single dose 100 mg orally 2x/day for 7 days erythromycin base7 500 mg orally 4x/day for 7 days erythromycin ethylsuccinate8 800 mg orally 4x/day for 7 days levofloxacin 500 mg 1x/day for 7 days ofloxacin 300 mg 2x/day for 7 days OR OR OR Recurrent NGU3,23,24 metronidazole25 tinidazole OR PLUS 2 g orally in a single dose 2 g orally in a single dose 1 g orally in a single doseazithromycin (if not used for initial episode) Nongonococcal Urethritis (NGU)
  • 14. Pediculosis Pubis Recommended Rx Dose/Route Alternatives permethrin 1% cream rinse pyrethrins with piperonyl butoxide OR Apply to affected area, wash off after 10 minutes Apply to affected area, wash off after 10 minutes malathion 0.5% lotion, applied 8-12 hrs then washed off ivermectin 250 µg/kg orally, repeated in 2 weeks OR Pediculosis Pubis
  • 15. Pelvic Inflammatory Disease Recommended Rx Dose/Route Alternatives 1. ceftriaxone doxycycline With OR metronidazole 2. cefoxitin doxycycline With OR metronidazole 3. Other parenteral third- generation cephalosporin (e.g. ceftizoxime or cefo- taxime) doxycycline With OR metronidazole PLUS Without PLUS Without PLUS Without 250 mg IM in a single dose 100 mg orally 2x/day for 14 days 500 mg orally 2x/day for 14 days 2 g IM in a single dose and probenecid, 1 g, orally administered concurrently in a single dose 100 mg orally 2x/day for 14 days 500 mg orally 2x/day for 14 days 100 mg orally 2x/day for 14 days 500 mg orally 2x/day for 14 days Pelvic Inflammatory Disease13 Alternative oral regimens are listed in CDC’s 2010 STD Treatment Guidelines.
  • 16. Scabies Recommended Rx Dose/Route Alternatives permethrin 5% cream ivermectin OR Apply to all areas of body from neck down, wash off after 8-14 hours 200 µg/kg orally, repeated in 2 weeks lindane 1%26,27 1 oz. of lotion or 30 g of cream, applied thinly to all areas of the body from the neck down, wash off after 8 hours Scabies
  • 17. Recommended Rx Dose/Route Alternatives Primary, secondary, or early latent 1 year benzathine penicillin G 2.4 million units IM in a single dose doxycycline6,28 100 mg 2x/day for 14 days tetracycline6,28 500 mg orally 4x/day for 14 days OR Latent 1 year, latent of unknown duration benzathine penicillin G 2.4 million units IM in 3 doses each at 1 week intervals (7.2 million units total) doxycycline6,28 100 mg 2x/day for 28 days tetracycline6,28 500 mg orally 4x/day for 28 days OR Pregnancy3 See complete CDC guidelines. Neurosyphilis aqueous crystalline penicillin G 3 to 4 million units IV every 4 hours for 10-14 days (18-24 million units/ day) procaine penicillin G 2.4 MU IM 1x daily probenecid 500 mg orally 4x/day, both for 10-14 days. PLUS Congenital syphilis aqueous crystalline penicillin G procaine penicillin G OR 100,000-150,000 units/kg/day (50,000 units/kg/dose IV every 12 hours) dur- ing the first 7 days of life and every 8 hours thereafter for a total of 10 days 50,000 units/kg/dose IM in a single dose for 10 days Children: Primary, secondary, or early latent 1 year benzathine penicillin G 50,000 units/kg IM in a single dose (maximum 2.4 million units) Children: Latent 1 year, latent of unknown duration benzathine penicillin G 50,000 units/kg IM for 3 doses at 1 week intervals (maximum total 7.2 million units) Syphilis Syphilis
  • 18. Trichomoniasis Recommended Rx Dose/Route Alternatives metronidazole25 tinidazole29 OR 2 g orally in a single dose 2 g orally in a single dose metronidazole25 500 mg 2x/day for 7 days Trichomoniasis
  • 19. 1. The recommended regimens are equally efficacious. 2. These creams are oil-based and may weaken latex condoms and diaphragms. Refer to product labeling for further information. 3. Please refer to the complete 2010 CDC Guidelines for recommended regimens. 4. Existing data do not support the use of topical agents in pregnancy. 5. Consider concurrent treatment for gonococcal infection if prevalence of gonorrhea is 5% (younger age). 6. Should not be administered during pregnancy, lactation, or to children 8 years of age. 7. If patient cannot tolerate high-dose erythromycin base schedules, change to 250 mg 4x/day for 14 days. 8. If patient cannot tolerate high-dose erythromycin ethylsuccinate schedules, change to 400 mg orally 4 times a day for 14 days. 9. Contraindicated for pregnant or lactating women. 10. Clinical experience and published studies suggest that azithromycin is safe and effective. 11. Erythromycin estolate is contraindicated during pregnancy. 12. Effectiveness of erythromycin treatment is approximately 80%; a second course of therapy may be required. 13. Patients who do not respond to oral therapy (within 72 hours) should be re-evaluated. 14 For patients with suspected sexually transmitted epididymitis, close follow-up is essential. 15. No definitive information available on prenatal exposure. 16. Treatment may be extended if healing is incomplete after 10 days of therapy. Indicates revision from the 2006 CDC Guidelines for the Treatment of Sexually Transmitted Diseases. Indicates update from the 2010 CDC Guidelines for the Treatment of Sexually Transmitted Diseases; see MMWR Morb Mortal Wkly Rep. 2012 Aug 10; 61(31):590-594 for details. Notes Notes
  • 20. 17. Consider discontinuation of treatment after one year to assess frequency of recurrence. 18. Vaginal, cervical, urethral meatal, and anal warts may require referral to an appropriate specialist. 19. CDC recommends that treatment for uncomplicated gonococcal infections of the cervix, urethra, and/or rectum should include dual therapy, i.e. both a cephalosporin (e.g. ceftriaxone) plus azithromycin (preferred) or doxycycline. 20. CDC recommends that cefixime in combination with azithromycin or doxycycline be used as an alternative when ceftriaxone is not available. 21. Only ceftriaxone is recommended for the treatment of pharyngeal infection. Providers should inquire about oral sexual exposure 22. Use with caution in hyperbilirubinemic infants, especially those born prematurely. 23. MSM are unlikely to benefit from the addition of nitroimidazoles. 24. Moxifloxacin 400mg orally 1x/day for 7 days effective against Mycoplasma genitalium 25. Pregnant patients can be treated with 2 g single dose. 26. Contraindicated for pregnant or lactating women, or children 2 years of age. 27. Do not use after a bath; should not be used by persons who have extensive dermatitis. 28. Pregnant patients allergic to penicillin should be treated with penicillin after desensitization. 29. Randomized controlled trials comparing single 2 g doses of metronidazole and tinidazole suggest that tinidazole is equivalent to, or superior to, metronidazole in achieving parasitologic cure and resolution of symptoms. Indicates revision from the 2006 CDC Guidelines for the Treatment of Sexually Transmitted Diseases. Indicates update from the 2010 CDC Guidelines for the Treatment of Sexually Transmitted Diseases; see MMWR Morb Mortal Wkly Rep. 2012 Aug 10; 61(31):590-594 for details. Notes (continued) Notes (continued)